GLIOTWIN is a Virtual Human Twin project designed to address two persistent blind spots in high-grade glioma: the invisible margin beyond what MRI can detect and the invisible onset of the disease.

The CancerScan Digital Twin System, developed by Neovivum Technologies within the EU-funded CancerScan project, has received EMA Breakthrough Device designation and will advance to structured expert guidance on its clinical and regulatory development pathway.